A carregar...
Refractory Colitis Following Anti-CTLA4 Antibody Therapy; Analysis of Mucosal FOXP3+ T Cells
Ipilimumab is a humanized antibody to CTLA4, used to treat cancers refractory to conventional treatment. We treated 21 patients with refractory melanoma or prostate cancer with anti-CTLA4 antibody (ipilimumab), with subsequent development of significant colitis in 9. Two of these nine did not respon...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2904314/ https://ncbi.nlm.nih.gov/pubmed/19507029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-009-0839-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|